Location
United States, North America
Check Size
$100K - $5M
Investment Stage
Seed
Series A
Series B
Focus Areas
BioTech
Pharmaceuticals
About Investor
Nassim Usman is the Chief Executive Officer & President of Totus Medicines and a Venture Partner at Morgenthaler Ventures. He focuses on biotechnology and pharmaceuticals from Seed through Series B, with a typical investment range of $100K–$5.0M. His prior roles include CEO of Catalyst Biosciences and senior leadership at Sirna Therapeutics/Ribozyme Pharmaceuticals.
Previous investments
Principia Biopharma
15M |2015
50M |2014
13M |2012
Similar Investors
AL
Abdul Ly
United States, North America
$1M - $4M
Seed
,Series A
,PS
Paul Straub
United States, North America
$100K - $2M
Pre Seed
,Seed
,SA
Shaun Abrahamson
United States, North America
$250K - $1M
Pre Seed
,Seed
,RF
Riley Florsheim
United States, North America
$100K - $5M
Pre Seed
,Seed
,SB
Steve Brownlie
United States, North America
$250K - $1.4M
Pre Seed
,Seed
,DG
Danielle Graham
Canada, North America
$100K - $300K
Pre Seed
,Seed
,Is this You?
Is this you? Have any edits?
Fill out our update request form and we'll update ASAP
Grow with the Right Investors
This profile is just one example. Our AI matches you with the investors who best fit your stage, industry, and vision.
Start Matching For Free